Successful Cystic Duct Stenting in a patient with Gallbladder Perforation and septic shock with Advanced Cirrhosis and Ascites: A Case Report

Abstract Gall bladder (GB) perforation and sepsis are common yet critical conditions frequently encountered in clinical practice. Acute cholecystitis, whether calculus or a calculous, can lead to GB perforation in 6–12% of cases.¹ The mortality rate of Gall Bladder perforation (GBP) has been reported to be between 12% and 16%.² Invasive surgical procedures present significant challenges, especially in patients with advanced liver disease. In particular, those with Child-Turcotte-Pugh (CTP) Class C cirrhosis face a high mortality rate ranging from 17% to 25% following cholecystectomy for acute cholecystitis. For these high-risk patients, less invasive alternatives such as percutaneous cholecystostomy or endoscopic placement of a lumen-apposing metal stent (LAMS) between the GB and gastrointestinal lumen are generally preferred due to their relatively greater safety profile.³ This case report describes a 55-year-old male with CTP-C cirrhosis and ascites who presented with GBP, peritonitis, and septic shock. Given his critical condition and the presence of ascites, Spy Glass cholangioscopy (SPY)-guided cystic duct stenting and gallbladder drainage were performed as a minimally invasive approach, followed by elective surgery once stabilized. The patient recovered well without significant complications. Although not the first reported case, such SPY-assisted cystic duct stenting for biliary drainage in a cirrhotic patient with ascites and septic shock due to GBP remains a rare and noteworthy therapeutic option in complex clinical scenarios where conventional surgical or percutaneous interventions carry high risks.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-06-30
DOI
https://doi.org/10.5281/zenodo.16758758
Primary Topic
Genetic and phenotypic traits in livestock
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Successful Cystic Duct Stenting in a patient with Gallbladder Perforation and septic shock with Advanced Cirrhosis and Ascites: A Case Report

Zenodo (CERN European Organization for Nuclear Research)
Genetic and phenotypic traits in livestock
article

Successful Cystic Duct Stenting in a patient with Gallbladder Perforation and septic shock with Advanced Cirrhosis and Ascites: A Case Report

article en

Abstract

Abstract Gall bladder (GB) perforation and sepsis are common yet critical conditions frequently encountered in clinical practice. Acute cholecystitis, whether calculus or a calculous, can lead to GB perforation in 6–12% of cases.¹ The mortality rate of Gall Bladder perforation (GBP) has been reported to be between 12% and 16%.² Invasive surgical procedures present significant challenges, especially in patients with advanced liver disease. In particular, those with Child-Turcotte-Pugh (CTP) Class C cirrhosis face a high mortality rate ranging from 17% to 25% following cholecystectomy for acute cholecystitis. For these high-risk patients, less invasive alternatives such as percutaneous cholecystostomy or endoscopic placement of a lumen-apposing metal stent (LAMS) between the GB and gastrointestinal lumen are generally preferred due to their relatively greater safety profile.³ This case report describes a 55-year-old male with CTP-C cirrhosis and ascites who presented with GBP, peritonitis, and septic shock. Given his critical condition and the presence of ascites, Spy Glass cholangioscopy (SPY)-guided cystic duct stenting and gallbladder drainage were performed as a minimally invasive approach, followed by elective surgery once stabilized. The patient recovered well without significant complications. Although not the first reported case, such SPY-assisted cystic duct stenting for biliary drainage in a cirrhotic patient with ascites and septic shock due to GBP remains a rare and noteworthy therapeutic option in complex clinical scenarios where conventional surgical or percutaneous interventions carry high risks.

Zenodo (CERN European Organization for Nuclear Research)
Advanced Pharma (US)
Good health and well-being
Openalex Percentile: Top 51%
Genetic and phenotypic traits in livestock
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.